Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate

被引:147
|
作者
Kawashima, Y [1 ]
Serigano, T [1 ]
Hino, T [1 ]
Yamamoto, H [1 ]
Takeuchi, H [1 ]
机构
[1] Gifu Pharmaceut Univ, Gifu 5028585, Japan
关键词
powders for inhalation; carrier lactose; particle morphology; crystalline form;
D O I
10.1016/S0378-5173(98)00202-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of surface morphology of carrier lactose on dry powder inhalation (DPI) property of pranlukast hydrate (PH) were investigated. The PH was mixed with 9-fold weights of carrier lactose, i.e. pharmatose 325M, 200M, DCL-11, DCL-21, spray dried amorphous (SDGa), -crystallized (SDGc) lactoses and fluidized bed granulated lactose (FBG) with various surface morphologies. These mixed powders were aerosolized by a Spinhaler(R) and in vitro deposition properties were evaluated by a twin impinger. Carrier lactose with higher specific surface area, i.e. surface roughness, like FBG emitted effectively PH particles from the inhalation device, whereas they reduced the respirable fraction captured in the twin impinger, resulting in lower inhalation efficiency, due to strong adhesion of PH to the carrier lactose. The SDGc having lots of microscopical projection on the surface increased the respirable particle percent of the emitted particles, improving the inhalation efficiency. The SDGa, smoothed sphere particle, did not so improve the inhalation efficiency as expected, owing to fairly strong adhesion between PH and lactose particles. Those finding indicated that the separation of drug particles from carrier lactose was a determining step to improve inhalation process for DPIs, as far as lactose particles emitted satisfactorily PH particles from the inhalation device. The surface morphology designed like SDGc, having fairly large surface area with microscopically increased surface roughness was desirable to improve inhalation property of DPI. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 50 条
  • [41] Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations
    Donovan, Martin J.
    Smyth, Hugh D. C.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 402 (1-2) : 1 - 9
  • [42] Use of recrystallized lactose as carrier for inhalation powder of interferon α2b
    Jiang, RG
    Pan, WS
    Wang, CL
    Liu, H
    [J]. PHARMAZIE, 2005, 60 (08): : 632 - 633
  • [43] THE EFFECT OF THE INHALATION FLOW ON THE PERFORMANCE OF A DRY POWDER INHALATION SYSTEM
    ZANEN, P
    VANSPIEGEL, PI
    VANDERKOLK, H
    TUSHUIZEN, E
    ENTHOVEN, R
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 81 (2-3) : 199 - 203
  • [44] A new spherically agglomerated drug composite system with lactose for dry powder inhalation
    Ikegami, K
    Kawashima, Y
    Takeuchi, H
    Yamamoto, H
    Mimura, K
    Momose, DI
    Ouchi, K
    [J]. ADVANCED POWDER TECHNOLOGY, 2003, 14 (02) : 215 - 229
  • [45] Binderless granulation of pharmaceutical fine powders with coarse lactose for dry powder inhalation
    Takano, K
    Nishii, K
    Horio, M
    [J]. POWDER TECHNOLOGY, 2003, 131 (2-3) : 129 - 138
  • [46] ROUND ROBIN OF PARTICLE SIZING METHOD OF A DRY POWDER INHALATION CARRIER
    Stadermann, David
    Boswinkel, Gerard
    Hebbink, Gerald
    Peters, Harry
    [J]. JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2018, 31 (02) : A4 - A4
  • [47] Spray dried progesterone formulations for carrier free dry powder inhalation
    Hibbard, Thomas
    Mitchell, Hannah
    Kim, Yoonha
    Shankland, Kenneth
    Al-Obaidi, Hisham
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2023, 189 : 264 - 275
  • [48] Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations
    Chan, LW
    Lim, LT
    Heng, PWS
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (05) : 975 - 984
  • [49] Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading
    Du, Ping
    Du, Ju
    Smyth, Hugh D. C.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (01) : 366 - 376
  • [50] Anaphylactic reaction after inhalation of Inavir® (Laminamivir Octanoate Hydrate), lactose-containing dry powder inhaler in milk-allergic children
    Yamaide, A.
    Ide, T.
    Tomiita, M.
    Hoshioka, A.
    Shimojo, N.
    [J]. ALLERGY, 2016, 71 : 475 - 475